Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

10592studies shown

Showing 4,717-4,728 of 10,592

Drug study icon

CompletedNCT02185131

Study of Mirtazapine for Co-occurring AD/MDD.

This study is completed in the United States. It focuses on Depression.

In United States

Depression, AddictionDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: University of Pittsburgh
Condition: Depression, Addiction

Drug study icon

CompletedNCT01338298

Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia

This study is completed in the United States. It is testing aripiprazole for schizophrenia.

In United States

SchizophreniaDrugFrom 18 Years to 50 Years

Countries: United States
Sponsor: University of Maryland, Baltimore
Condition: Schizophrenia

Drug study icon

TerminatedNCT00805493

Study of Riluzole in Pediatric Bipolarity

This study was terminated in the United States. It focuses on Bipolarity.

In United States

Bipolarity, Depression, ...DrugFrom 9 Years to 17 Years

Countries: United States
Sponsor: National Institute of Mental Health (NIMH)
Condition: Bipolarity, Depression, ...

Behavioral study icon

CompletedNCT01242371

Study of a Probiotic Supplement to Reduce the Symptoms of Schizophrenia

This study is completed in the United States. It focuses on schizophrenia.

In United States

SchizophreniaBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: Sheppard Pratt Health System
Condition: Schizophrenia

Drug study icon

CompletedNCT00194116

Divalproex Sodium ER in Bipolar I or Bipolar II Depression

This study is completed in the United States. It focuses on depression.

In United States

Bipolarity, DepressionDrugFrom 16 Years to 65 Years

Countries: United States
Sponsor: University Hospitals Cleveland Medical Center
Condition: Bipolarity, Depression

Drug study icon

CompletedNCT00784654

Safety study of LDX in ADHD

This study is completed in the United States, in France, in the United Kingdom, .... It is testing LDX for ADHD.

In United States

ADHDDrugFrom 6 Years to 17 Years

Countries: United States, France, United Kingdom, ...
Sponsor: Shire
Condition: ADHD

Drug study icon

CompletedNCT01437046

Doxazosin an a1 Antagonist for Alcohol Dependence

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AnxietyDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Brown University
Condition: Anxiety

Drug study icon

CompletedNCT02308202

DOXAZOSIN FOR PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Baylor College of Medicine
Condition: PTSD

Behavioral study icon

CompletedNCT06838351

Drawing and Anxiety Study

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AnxietyBehavioralFrom 13 Years to 25 Years

Countries: United States
Sponsor: Penn State University
Condition: Anxiety

Behavioral study icon

CompletedNCT05427734

Drivers of Suicide Mobile App Study

This summary needs review. Please check the official study record and contact the research team for details.

Remote / online

Suicidality, AddictionBehavioralOver 22 Years

Countries: United States
Sponsor: Evidence-Based Practice Institute, Seattle, WA
Condition: Suicidality, Addiction

Drug study icon

CompletedNCT00217971

Dronabinol Treatment for Marijuana Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: Addiction

Behavioral study icon

CompletedNCT00816231

Drug /Cue Interactions In Alcohol-Tobacco Comorbidity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 21 Years to 55 Years

Countries: United States
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Condition: Addiction

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.